{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:26:54Z","timestamp":1721176014328},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,16]]},"DOI":"10.7759\/cureus.64650","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T15:11:04Z","timestamp":1721142664000},"source":"Crossref","is-referenced-by-count":0,"title":["Development of Myelodysplastic Syndrome in a Patient With Pernicious Anemia During the Course of Replacement Treatment"],"prefix":"10.7759","author":[{"given":"Yoshiki","family":"Uemura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuto","family":"Togitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Kitaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2019.1622382","article-title":"Pernicious anemia: a myelodysplastic syndrome look-alike","volume":"9","author":"Kesbeh Y","year":"2019","unstructured":"Kesbeh Y, Pakbaz Z. Pernicious anemia: a myelodysplastic syndrome look-alike. J Community Hosp Intern Med Perspect. 2019, 9:240-3. 10.1080\/20009666.2019.1622382","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref2","article-title":"[Clinically relevant possibilities and limits of differential diagnosis of megaloblastic anemia and myelodysplastic syndrome\u00a0- refractory anemia type in bone marrow biopsies]","volume":"62","author":"Va\u0161ekov\u00e1 P","year":"2016","unstructured":"Va\u0161ekov\u00e1 P, Sz\u00e9pe P, Marcinek J, Balh\u00e1rek T, Plank L. [Clinically relevant possibilities and limits of differential diagnosis of megaloblastic anemia and myelodysplastic syndrome\u00a0- refractory anemia type in bone marrow biopsies]. Vnitr Lek. 2016, 62:692-7.","journal-title":"Vnitr Lek"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199605000-00013","article-title":"Transient 7q- in association with megaloblastic anemia due to dietary folate and vitamin B12 deficiency","volume":"18","author":"Wollman MR","year":"1996","unstructured":"Wollman MR, Penchansky L, Shekhter-Levin S. Transient 7q- in association with megaloblastic anemia due to dietary folate and vitamin B12 deficiency. J Pediatr Hematol Oncol. 1996, 18:162-5. 10.1097\/00043426-199605000-00013","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s002770000272","article-title":"Concurrent pernicious anemia and myelodysplastic syndrome","volume":"80","author":"Drabick JJ","year":"2001","unstructured":"Drabick JJ, Davis BJ, Byrd JC. Concurrent pernicious anemia and myelodysplastic syndrome. Ann Hematol. 2001, 80:243-5. 10.1007\/s002770000272","journal-title":"Ann Hematol"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V25.5.662.662","article-title":"Chromosomal aberrations in pernicious anemia. Study of three cases before and after therapy","volume":"25","author":"Kiossoglou KA","year":"1965","unstructured":"Kiossoglou KA, Mitus WJ, Dameshek W. Chromosomal aberrations in pernicious anemia. Study of three cases before and after therapy. Blood. 1965, 25:662-82.","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-160612","article-title":"Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes","volume":"17","author":"Kobayashi S","year":"2016","unstructured":"Kobayashi S, Ueda Y, Nannya Y, et al.. Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes. Cancer Biomark. 2016, 17:21-32. 10.3233\/CBM-160612","journal-title":"Cancer Biomark"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1989.169","article-title":"Cancer risk following pernicious anaemia","volume":"59","author":"Brinton LA","year":"1989","unstructured":"Brinton LA, Gridley G, Hrubec Z, Hoover R, Fraumeni JF Jr. Cancer risk following pernicious anaemia. Br J Cancer. 1989, 59:810-3. 10.1038\/bjc.1989.169","journal-title":"Br J Cancer"},{"key":"ref8","article-title":"[Pernicious anemia as the initial phase of an acute erythro-leukemia]","volume":"80","author":"Heilmeyer L","year":"1950","unstructured":"Heilmeyer L. [Pernicious anemia as the initial phase of an acute erythro-leukemia]. Schweiz Med Wochenschr. 1950, 80:1122-4.","journal-title":"Schweiz Med Wochenschr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.10.3.258","article-title":"Pernicious anaemia complicated by granulocytic leukaemia","volume":"10","author":"Blackburn EK","year":"1957","unstructured":"Blackburn EK. Pernicious anaemia complicated by granulocytic leukaemia. J Clin Pathol. 1957, 10:258-61. 10.1136\/jcp.10.3.258","journal-title":"J Clin Pathol"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V91.8.2969.2969_2969_2976","article-title":"Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells","volume":"91","author":"Inoue K","year":"1998","unstructured":"Inoue K, Tamaki H, Ogawa H, et al.. Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells. Blood. 1998, 91:2969-76.","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13664","article-title":"Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1-mRNA expression in patients with AML and MDS","volume":"107","author":"Rautenberg C","year":"2021","unstructured":"Rautenberg C, Lauseker M, Kaivers J, et al.. Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1-mRNA expression in patients with AML and MDS. Eur J Haematol. 2021, 107:283-92. 10.1111\/ejh.13664","journal-title":"Eur J Haematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2170","article-title":"A 20-year perspective on the International Fanconi Anemia Registry (IFAR)","volume":"101","author":"Kutler DI","year":"2003","unstructured":"Kutler DI, Singh B, Satagopan J, et al.. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood. 2003, 101:1249-56. 10.1182\/blood-2002-07-2170","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11046","article-title":"Cancer in Fanconi anemia, 1927-2001","volume":"97","author":"Alter BP","year":"2003","unstructured":"Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer. 2003, 97:425-40. 10.1002\/cncr.11046","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1498","article-title":"Cancer incidence in persons with Fanconi anemia","volume":"101","author":"Rosenberg PS","year":"2003","unstructured":"Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood. 2003, 101:822-6. 10.1182\/blood-2002-05-1498","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0142(19941001)74:7+<2092::AID-CNCR2820741717>3.0.CO;2-G","article-title":"Biology of aging as related to cancer","volume":"74","author":"Cohen HJ","year":"1994","unstructured":"Cohen HJ. Biology of aging as related to cancer. Cancer. 1994, 74:2092-100.","journal-title":"Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/266111-development-of-myelodysplastic-syndrome-in-a-patient-with-pernicious-anemia-during-the-course-of-replacement-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T15:13:06Z","timestamp":1721142786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/266111-development-of-myelodysplastic-syndrome-in-a-patient-with-pernicious-anemia-during-the-course-of-replacement-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.64650","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,16]]}}}